These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32240516)

  • 1. Treatment studies with cannabinoids in anorexia nervosa: a systematic review.
    Rosager EV; Møller C; Sjögren M
    Eat Weight Disord; 2021 Mar; 26(2):407-415. PubMed ID: 32240516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS.
    Lutge EE; Gray A; Siegfried N
    Cochrane Database Syst Rev; 2013 Apr; (4):CD005175. PubMed ID: 23633327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do cannabinoids constitute a therapeutic alternative for anorexia nervosa?
    Contreras T; Bravo-Soto GA; Rada G
    Medwave; 2017 Dec; 17(9):e7095. PubMed ID: 29194432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dronabinol in severe, enduring anorexia nervosa: a randomized controlled trial.
    Andries A; Frystyk J; Flyvbjerg A; Støving RK
    Int J Eat Disord; 2014 Jan; 47(1):18-23. PubMed ID: 24105610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cannabinoids in palliative care: Systematic review and meta-analysis of efficacy, tolerability and safety].
    Mücke M; Carter C; Cuhls H; Prüß M; Radbruch L; Häuser W
    Schmerz; 2016 Feb; 30(1):25-36. PubMed ID: 26809975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Cannabinoids for Treatment of Dementia: A Systematic Review of Randomized Controlled Trials.
    Charernboon T; Lerthattasilp T; Supasitthumrong T
    Clin Gerontol; 2021; 44(1):16-24. PubMed ID: 32186469
    [No Abstract]   [Full Text] [Related]  

  • 7. The Impact of Δ9-THC on the Psychological Symptoms of Anorexia Nervosa: A Pilot Study.
    Avraham Y; Latzer Y; Hasid D; Berry EM
    Isr J Psychiatry; 2017; 54(3):44-51. PubMed ID: 29735812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are antipsychotics effective for the treatment of anorexia nervosa? Results from a systematic review and meta-analysis.
    Kishi T; Kafantaris V; Sunday S; Sheridan EM; Correll CU
    J Clin Psychiatry; 2012 Jun; 73(6):e757-66. PubMed ID: 22795216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential of cannabinoids in managing cancer-related anorexia in older adults: a systematic review of the literature.
    Ceolin C; De Rui M; Ravelli A; Papa MV; Devita M; Sergi G; Coin A
    J Nutr Health Aging; 2024 Aug; 28(8):100299. PubMed ID: 38917597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer cachexia and cannabinoids.
    Gorter RW
    Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():21-2. PubMed ID: 10575285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications.
    Bilbao A; Spanagel R
    BMC Med; 2022 Aug; 20(1):259. PubMed ID: 35982439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoids in Pain Management and Palliative Medicine.
    Häuser W; Fitzcharles MA; Radbruch L; Petzke F
    Dtsch Arztebl Int; 2017 Sep; 114(38):627-634. PubMed ID: 29017688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy and acceptability of psychological interventions for the treatment of adult outpatients with anorexia nervosa: a systematic review and network meta-analysis.
    Solmi M; Wade TD; Byrne S; Del Giovane C; Fairburn CG; Ostinelli EG; De Crescenzo F; Johnson C; Schmidt U; Treasure J; Favaro A; Zipfel S; Cipriani A
    Lancet Psychiatry; 2021 Mar; 8(3):215-224. PubMed ID: 33600749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonergic and dopaminergic systems in anorexia nervosa: a role for atypical antipsychotics?
    Bosanac P; Norman T; Burrows G; Beumont P
    Aust N Z J Psychiatry; 2005 Mar; 39(3):146-53. PubMed ID: 15701063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in IGF-I, urinary free cortisol and adipokines during dronabinol therapy in anorexia nervosa: Results from a randomised, controlled trial.
    Andries A; Frystyk J; Flyvbjerg A; Støving RK
    Growth Horm IGF Res; 2015 Oct; 25(5):247-52. PubMed ID: 26248813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies].
    Petzke F; Enax-Krumova EK; Häuser W
    Schmerz; 2016 Feb; 30(1):62-88. PubMed ID: 26830780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Systematic Review of the Efficacy of Cannabinoid Agonist Replacement Therapy for Cannabis Withdrawal Symptoms.
    Werneck MA; Kortas GT; de Andrade AG; Castaldelli-Maia JM
    CNS Drugs; 2018 Dec; 32(12):1113-1129. PubMed ID: 30361897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs related to tetrahydrocannabinol.
    Razdan RK; Howes JF
    Med Res Rev; 1983; 3(2):119-46. PubMed ID: 6134882
    [No Abstract]   [Full Text] [Related]  

  • 19. Systematic review and meta-analysis of cannabinoids in palliative medicine.
    Mücke M; Weier M; Carter C; Copeland J; Degenhardt L; Cuhls H; Radbruch L; Häuser W; Conrad R
    J Cachexia Sarcopenia Muscle; 2018 Apr; 9(2):220-234. PubMed ID: 29400010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoids in medicine: A review of their therapeutic potential.
    Ben Amar M
    J Ethnopharmacol; 2006 Apr; 105(1-2):1-25. PubMed ID: 16540272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.